Pancreatectomy is the surgical removal of all or part of the pancreas. It is an advanced and comprehensive surgical treatment used for pancreatic diseases, with the goal of removing diseased tissue from the body. Because this procedure directly affects digestion and the body’s blood sugar balance (endocrine function), it requires a highly specialized, multidisciplinary approach and meticulous follow-up both during and after surgery.
You can contact Prof. Dr. Ebru Soy, one of the doctors performing Pancreatectomy in Ankara, to get information about Pancreatectomy prices, the process, and the hospital where Pancreatectomy is performed.
Education;
High School: TED Ankara College – Graduation: 1998
Faculty of Medicine: Hacettepe University Faculty of Medicine – Graduation: 2005
Specialization: General Surgery Residency Training – Başkent University Faculty of Medicine, Department of General Surgery – 2012
Post-Specialization Career;
2012–2014: Compulsory public service – Muş State Hospital
January 2014 – November 2022: Başkent University Faculty of Medicine, Department of General Surgery – Served as a specialist physician and later as an academician
March 2016 – October 2017: Başkent University Istanbul Practice Hospital – Deputy Director Responsible for Liver Transplantation
June 2020 – November 2022: Başkent University Ankara Hospital – Director of the International Patient Department
What Is Pancreatectomy?
Pancreatectomy is the surgical removal of part of the pancreas (partial) or the entire pancreas (total). It is commonly performed for pancreatic tumors, cysts, trauma, or inflammatory diseases. The type of operation depends on the lesion’s location and extent. After total pancreatectomy, patients require lifelong insulin and pancreatic enzyme supplementation. This is a complex, high-precision surgery that must be planned with a multidisciplinary approach.
Why is pancreatic surgery (pancreatectomy) necessary?
There are many reasons why pancreatic surgery is performed. The most common and most important reason is pancreatic cancer. However, not every pancreatic operation is done for cancer. The main conditions that may require surgery include:
- Pancreatic cancers (most commonly PDAC)
- Pancreatic neuroendocrine tumors (pNET)
- Cysts with a risk of malignant transformation (such as IPMN)
- Severe, treatment-resistant pain due to chronic pancreatitis
- Metastases to the pancreas from other organs (rare)
How many types of pancreatic surgery are there?
The type of surgery changes fundamentally depending on where the disease is located in the pancreas. If we compare the pancreas to a fish, it has a broad “head,” a “body,” and a narrow “tail”:
- Whipple Procedure (Pancreaticoduodenectomy):
This is the most well-known and the largest pancreatic operation, typically performed for tumors in the head of the pancreas. In this surgery, not only the pancreatic head but also the duodenum, part of the stomach, the gallbladder, and a portion of the main bile duct are removed. After resection, reconstruction is required—meaning the remaining pancreas, stomach, and bile duct must be reconnected to the small intestine.
- Distal Pancreatectomy:
This operation is performed for lesions in the body and tail (left side) of the pancreas. The tail portion is removed, and because the spleen lies very close to this area, it is often removed as well. However, with modern minimally invasive techniques, spleen preservation (spleen-preserving distal pancreatectomy) may be possible.
- Total Pancreatectomy:
This is the removal of the entire pancreas. It is performed only in highly selected situations, such as when the tumor involves the whole gland, in certain genetic syndromes, or when chronic pancreatitis has destroyed the entire pancreas. After this operation, patients become permanently dependent on both insulin (for blood sugar control) and digestive enzymes.
How is pancreatic cancer surgery planned?
Pancreatic cancer surgery begins with deciding whether the tumor is “resectable” (removable). For this decision, high-resolution, specialized contrast-enhanced CT scans—and sometimes MRI—are used. The goal is to assess, in millimeter-level detail, the tumor’s relationship with vital nearby arteries and veins.
The only objective of surgery is to remove the tumor with no cancer cells left behind. This is called an “R0 resection” or “negative (clean) surgical margin,” and it is the most critical factor—and often the only chance—for long-term survival in pancreatic cancer.
If the tumor is close to major vessels, what does “borderline” mean?
Imaging classifies the disease into three main groups based on the tumor’s relationship with blood vessels.
First are Resectable tumors, where the tumor is clearly away from major vessels and the first option is usually upfront surgery.
Second are Locally Advanced (Unresectable) tumors, where the tumor completely encases major arteries (such as the SMA or celiac artery), making a margin-negative resection technically impossible.
The third—and the group most targeted by modern treatment—is Borderline Resectable tumors. Here, the tumor is “abutting” or in “contact” with vessels. Although technically removable, proceeding directly to surgery carries a high risk of leaving microscopic disease behind (R1). This is why treatment strategy has changed significantly for this group.
Why do some pancreatic cancer patients receive chemotherapy before surgery?
In the past, “borderline” tumors were either not operated on or were operated on with a high risk of leaving tumor behind. Modern practice has shifted: patients identified as “borderline” or “locally advanced” are now often treated first with chemotherapy (and sometimes radiotherapy). This is called neoadjuvant therapy.
This approach has two main goals. First, chemotherapy can shrink the tumor and potentially “pull it away” from major vessels, making surgery safer and more likely to achieve a clean margin.
Second—and often more importantly—it serves as a biologic test. Pancreatic cancer can spread microscopically early on. If the tumor shrinks with strong chemotherapy (such as FOLFIRINOX), it suggests the disease biology is responsive and the patient is more likely to benefit from major surgery. If the tumor continues to grow despite therapy, it may indicate an aggressive biology where surgery would not provide durable benefit.
In short, preoperative chemotherapy helps select patients who truly benefit from surgery and begins treating hidden micrometastatic disease before the burden of a major operation.
Why must these pancreatic operations be performed at experienced centers?
Pancreatic surgery is among the most complex, technically demanding, and high-risk operations in surgery. The surgery itself—and the management of postoperative care and complications—requires substantial expertise.
Large international studies have clearly shown that outcomes are directly related to a hospital’s experience and case volume. In high-volume centers (often defined as performing more than 20–30 pancreatic operations per year), complication rates and surgery-related mortality are significantly lower.
Therefore, these procedures should be performed in experienced centers with specialized pancreatic surgeons and access to well-equipped intensive care, interventional radiology, and gastroenterology services.
What is the difference between open pancreatic surgery and minimally invasive (robotic) surgery?
Open surgery is the traditional method in which the abdomen is opened with a large incision, typically through the midline or under the ribs. The surgeon operates directly with hands and direct vision.
Minimally invasive surgery is performed through several small incisions (ports) instead of one large cut. A camera and surgical instruments are inserted through these ports. There are two main types: laparoscopic surgery (with straight instruments) and robotic surgery.
In robotic surgery, the surgeon operates from a console, controlling advanced robotic arms that can replicate wrist-like movements in 3D, rotate through wide angles, and filter out tremor. This provides major precision advantages, especially in narrow and deep surgical fields.
Which approach is better for distal (pancreatic tail) surgery?
For tumors in the body and tail of the pancreas (distal lesions), minimally invasive approaches are now considered the “gold standard.” Laparoscopic and robotic distal pancreatectomy offer important advantages over open surgery, including:
- Less postoperative pain
- Smaller scars (better cosmetic results)
- Shorter hospital stay
- Faster return to normal diet and daily life
- Lower rates of some complications (such as delayed gastric emptying)
- Less blood loss
Large studies have demonstrated that, for cancer outcomes (clean tumor removal), these approaches are oncologically comparable to open surgery, while enabling faster recovery and improved quality of life.
Is robotic surgery safe for the Whipple (pancreatic head) procedure?
The Whipple procedure (pancreaticoduodenectomy) is far more complex than distal pancreatectomy because it includes not only resection but also reconstruction—reconnecting the stomach, pancreas, and bile duct to the small intestine. This reconstruction (anastomosis) is the most delicate phase of the operation.
Because of this complexity, minimally invasive Whipple surgery spread more slowly. However, robotic surgery has made a major impact in this field. The robot’s 3D depth perception, tremor elimination, and superior maneuverability in confined spaces provide meaningful advantages, especially during precision suturing (such as connecting the pancreas to the intestine).
Laparoscopic Whipple is technically extremely difficult, whereas robotic Whipple (RPD) is increasingly recognized as a technique that combines the safety of open surgery with the recovery advantages of minimally invasive surgery (less trauma, less blood loss, faster recovery).
Importantly, recent studies suggest that patients undergoing robotic Whipple can often start their crucial postoperative chemotherapy earlier and tolerate full dosing more effectively. Earlier recovery can support timely continuation of cancer treatment, which may positively influence long-term outcomes.
Is the most feared risk of pancreatic surgery “pancreatic leak”?
Yes. The most important and most feared complication is a postoperative pancreatic fistula (POPF), meaning leakage of pancreatic fluid (digestive enzymes) into the abdomen—especially after the Whipple procedure, at the site where the pancreas is connected to the intestine.
The pancreas produces very powerful digestive enzymes, and its tissue is often soft—making it difficult to hold stitches securely. When leakage occurs, these enzymes can damage nearby tissues and even erode major vessels, leading to serious infections and life-threatening bleeding. For this reason, a major focus of pancreatic surgery is preventing leaks and managing them effectively if they occur.
Are there specific techniques to reduce the risk of pancreatic leak?
Yes. Over time, surgeons have developed and refined multiple reconstruction techniques to reduce POPF risk. Among modern, well-studied methods, the Blumgart anastomosis stands out.
Rather than relying on simple sutures alone, this technique creates a reinforced, multi-layer “seal” by anchoring the pancreas securely and wrapping it to reduce tension on the suture line—similar to building a gasket system. Robotic surgery, with its precise suturing capabilities, can make applying these advanced techniques easier and more consistent.
While no technique can eliminate leaks entirely, these approaches can reduce leak severity—shifting the risk from catastrophic, life-threatening leaks to milder, more manageable ones.
What happens if a pancreatic leak develops after surgery?
Pancreatic fistulas are managed according to internationally accepted grading systems, which guide treatment based on severity:
- Grade A (Biochemical leak): The mildest form. The patient has no symptoms (no fever, no pain). Only laboratory testing of drain fluid shows elevated pancreatic enzymes. This is not dangerous and typically resolves on its own.
- Grade B (Clinically relevant leak): The patient may develop fever, abdominal pain, or infection signs. The drain may need to remain longer, antibiotics may be required, and sometimes an additional radiology-guided drain (percutaneous drainage) is placed to empty fluid collections. Most cases can be managed without reoperation, with support from interventional radiology and infection specialists.
- Grade C (Severe leak): The most serious, life-threatening situation. It can cause sepsis (organ failure) or major bleeding. The patient usually requires intensive care and often urgent reoperation.
Modern pancreatic care focuses on preventing Grade C fistulas and recognizing Grade B fistulas early, treating them aggressively with minimally invasive methods to prevent deterioration.
Why is the pathology report so important after pancreatic surgery?
After surgery, the removed specimen (pancreas, intestine, lymph nodes) is sent to pathology for microscopic evaluation. The most critical factor is the surgical margin—how close tumor cells are to the cut edge.
If tumor cells reach the margin or are closer than 1 mm, this is considered R1 (microscopically positive), meaning disease may have been left behind. If tumor cells are at least 1 mm away from the margin, this is considered R0 (negative/clean margin), indicating the tumor has been removed completely.
Standardized, detailed pathology reporting is essential to guide postoperative treatment decisions, such as whether additional chemotherapy or radiotherapy is needed.
What happens if the entire pancreas is removed (Total Pancreatectomy)?
Diabetes can develop after partial pancreatectomy (Whipple or distal), but after total pancreatectomy, diabetes is inevitable because no pancreatic tissue remains.
However, this is not like typical Type 1 or Type 2 diabetes. It is called Type 3c diabetes or “brittle diabetes,” because the body cannot produce not only insulin but also glucagon—the hormone that raises blood sugar during emergencies when it falls too low.
Without glucagon, patients are highly vulnerable to dangerous episodes of hypoglycemia (sudden low blood sugar). Managing this “brittle” diabetes is challenging and requires specialized endocrine care, often supported by advanced technologies:
- Continuous glucose monitoring systems (CGMS)
- Insulin pumps (CSII)
These devices can be vital for preventing life-threatening hypoglycemia.
Do digestive problems occur after pancreatic surgery?
Yes, and this is both common and clinically important. One of the pancreas’s main functions is producing enzymes that digest fats, proteins, and carbohydrates. When the pancreatic head (Whipple) or the entire pancreas (total pancreatectomy) is removed, enzyme delivery to the intestine can become insufficient.
This is called Pancreatic Exocrine Insufficiency (PEI). Food—especially fat—is poorly digested and absorbed. Symptoms may include:
- Chronic diarrhea
- Foul-smelling, greasy, sticky stools
- Rapid weight loss despite eating
- Persistent gas and bloating
- Vitamin deficiencies (especially A, D, E, K)
Is there a treatment for exocrine insufficiency (PEI)?
Yes. The treatment is relatively straightforward but must be lifelong: PERT (Pancreatic Enzyme Replacement Therapy).
Patients take pancreatic enzyme capsules with every meal (main meals and snacks). These enzymes replace what the pancreas can no longer produce, enabling digestion and absorption to return toward normal.
This is not optional. A patient who cannot maintain nutrition and continues to lose weight will not have the strength to recover well, tolerate chemotherapy, or fight cancer effectively. Nutritional and enzyme support is a core pillar of pancreatic cancer care—alongside surgery and oncology.
What does “success” mean in pancreatic surgery?
As you can see, success in modern pancreatic surgery is not only removing the tumor with a clean margin in the operating room. Success is holistic. Key elements include:
- Accurate patient selection and rational planning (including preoperative chemotherapy when appropriate)
- An experienced surgical team and a well-equipped center
- Performing surgery with the least possible trauma (robotic when appropriate)
- Helping the patient recover fast enough to receive chemotherapy
- Early recognition of complications (such as leaks)
- Managing complications with modern, non-surgical methods when possible
- Lifelong expert support for diabetes and digestive function
Pancreatectomy requires a fully multidisciplinary team—surgeon, oncologist, radiologist, gastroenterologist, and endocrinologist—focused on both oncologic control and long-term metabolic health.
Frequently Asked Questions
How Long Does a Pancreatectomy Take?
Pancreatectomy is a major operation involving removal of part or all of the pancreas and typically takes about 4 to 8 hours. The duration depends on the extent of the procedure (distal, total, or Whipple), the patient’s overall condition, and any additional complexities.
Which Doctor Should You See for a Pancreatectomy?
You should consult a general surgeon—preferably one experienced in hepatopancreatobiliary (HPB) surgery (liver, pancreas, and biliary surgery)—for evaluation and treatment planning.

